Form 4: Seer Director Isaac Ro to Receive Future Equity Grants

Seer, Inc. Director Isaac Ro is scheduled to receive grants of restricted stock units and stock options on September 2, 2025, vesting over three years.

Summary

• Isaac Ro, a Director of Seer, Inc. (SEER), is set to acquire 41,000 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) on September 2, 2025.
• These 41,000 RSUs will vest in three equal annual installments, commencing on September 2, 2026.
• Additionally, Ro will acquire 61,000 stock options, with an exercise price of $2.04 per share, on September 2, 2025.
• The 61,000 stock options will also vest in three equal annual installments, beginning on September 2, 2026, and have an expiration date of September 2, 2035.
• The transaction is reported as an acquisition (A) for both non-derivative and derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as equity grants align management incentives with shareholder interests, which is generally viewed favorably. However, it's a routine compensation event rather than a significant operational or financial announcement.

Positives

• The equity grants align the Director's interests with those of shareholders, incentivizing long-term performance and value creation.
• The vesting schedule encourages long-term commitment and retention of key management personnel.

Negatives

• The issuance of new equity (RSUs and options) could lead to potential future dilution for existing shareholders when the shares vest or options are exercised.

Risks

• Future stock price volatility could impact the value of the stock options and RSUs, affecting the incentive's effectiveness.
• The vesting schedule ties compensation to continued employment, which could be a risk if the director departs before full vesting.

Future Outlook

The filing indicates a future grant of equity compensation to a director, with vesting scheduled over the next three years, suggesting an expectation of continued service and performance from the individual.

Industry Context

Equity compensation, including restricted stock units and stock options, is a standard practice across the biotechnology and life sciences industries to attract, retain, and incentivize key talent, particularly directors and executives, by aligning their financial interests with the long-term success of the company.

Stakeholder Impact

• Shareholders: Potential for future dilution from the vesting and exercise of equity awards, but also benefit from aligned management incentives.
• Director (Isaac Ro): Receives significant equity compensation, increasing his stake and financial interest in the company's performance.

Next Steps

• The RSUs and stock options will begin vesting in three equal annual installments starting September 2, 2026.

Key Dates

Keywords

Seer Inc., SEER, Isaac Ro, Director, Restricted Stock Units, RSUs, Stock Options, Equity Grant, Insider Transaction, Compensation, Vesting